Streetbeat News

Regulatory

VLCN

Volcon ePowersports has announced a research and development agreement with the United States Army Engineer Research and Development Center. The details of the agreement and its potential impact on Volcon's operations and financials were not disclosed.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:32 pm

AAPL

ASML

QCOM

TSM

Huawei's new smartphone series, powered by its proprietary Kirin 9000s chips, has sparked concerns in the US about its ability to curb China's tech ambitions. The Kirin 9000s chips deliver comparable performance to Qualcomm's Snapdragon 888. The US is reportedly planning to update its restrictions on the export of AI chips and semiconductor production equipment to China. Huawei continues to be one of Qualcomm’s major customers, purchasing between 23 million and 25 million chips from Qualcomm last year. However, if Huawei can produce the Kirin 9000s chip at a slightly higher cost, it may reduce its purchase of some of its higher-end chips from Qualcomm next year.

Portfolio Pulse from The Bamboo Works

October 10, 2023 | 1:27 pm

OMEX

Odyssey Marine Exploration, Inc. has received a letter from the International Centre for Settlement of Investment Disputes (ICSID) stating that the tribunal is close to completing the drafting of the award and expects to issue it in Q1 2024. Any changes to the timing estimate will be duly notified to the claimant.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 1:22 pm

CGC

Canopy Growth Corporation (NASDAQ:CGC) has received EU GMP certification for its cannabis cultivation facility in Kincardine, Ontario. This certification allows the company to continue exporting certified medical cannabis to medical markets in Europe and globally. The company's shares traded 5.04% higher in Tuesday’s pre-market session.

Portfolio Pulse from Nina Zdinjak

October 10, 2023 | 1:18 pm

CAPR

Capricor Therapeutics (NASDAQ:CAPR) presented data at the 28th Annual Congress of the World Muscle Society, showing the sustained efficacy and safety of CAP-1002 in treating Duchenne Muscular Dystrophy. The data also highlighted the potential of the company's StealthX™ technology in enhancing the delivery of antisense oligonucleotides. The company plans to report the outcome of the interim futility analysis in Q4 2023 and top-line data in late 2024.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 1:17 pm

AMLX

Amylyx Pharmaceuticals has announced the publication of a survival analysis comparing the long-term survival of participants in the CENTAUR study versus a historical clinical trial control group. The results of this study could have significant implications for the company's future drug development and approval processes.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:16 pm

BTCUSD

Ryan Selkis, CEO of Messari, a crypto market intelligence provider, celebrated a decade in the cryptocurrency industry by revealing his purchase of 10 Bitcoin (BTC) in 2013 for $135 per unit. With the current trading price of Bitcoin at $27,655.48 per unit, his initial investment would have increased by over 20,000%. Amid regulatory actions targeting major cryptocurrency exchanges, Selkis announced the establishment of a new advocacy group, @DFA2024, to combat fear, uncertainty, and doubt in the crypto sector.

Portfolio Pulse from Mehab Qureshi

October 10, 2023 | 1:13 pm

BFRI

Biofrontera Inc. has received FDA approval for a new formulation of its product, Ameluz.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 1:06 pm

SPY

The USA Redbook Year-over-Year (YoY) has increased to 4% from the previous 3.5%.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 12:57 pm

CBWTF

Italy's Lazio Regional Court has suspended a decree prohibiting the sale of cannabinoid-based products for oral use or ingestion. In Canada, the cannabis 'strategy table' has selected Hugo Alves, CEO of Auxly Cannabis Group (OTCQB:CBWTF), as its chair. The group aims to improve the government's understanding of the cannabis sector's economic situation. In Australia, medical marijuana approvals have increased by over 120% in H1 2023 compared to the same period in 2022. A draft bill in Tasmania proposes the destruction of crops exceeding the 1.0% THC limit.

Portfolio Pulse from Nina Zdinjak

October 10, 2023 | 12:54 pm